ROK
67
5
FLS
76
-2
AIG
47
6
GS
75
-4
DVA
72
-3
WMB
68
-2
FLR
48
3
ACN
70
5
KO
44
2
EXR
59
4
DOW
30
2
HSY
43
3
URBN
66
2
RCL
88
-2
SJM
16
-3
KLAC
45
-4
FRT
48
2
SIG
47
-2
HCP
70
-4
QRVO
4
-2
ROK
67
5
FLS
76
-2
AIG
47
6
GS
75
-4
DVA
72
-3
WMB
68
-2
FLR
48
3
ACN
70
5
KO
44
2
EXR
59
4
DOW
30
2
HSY
43
3
URBN
66
2
RCL
88
-2
SJM
16
-3
KLAC
45
-4
FRT
48
2
SIG
47
-2
HCP
70
-4
QRVO
4
-2
Financhill
Back

The Carlyle Group 10K Form

Buy
73

CG
The Carlyle Group

Last Price:
51.07
Seasonality Move:
9.29%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CG News And Ratings

See the #1 stock for the next 7 days that we like better than CG

CG Financial Statistics

Sales & Book Value

Annual Sales: $1.32B
Cash Flow: $772.8M
Price / Cash Flow: 0
Annual Sales: $15.51
Price / Book: 3.37

Profitability

EPS (TTM): 0.30000
Net Income (TTM): $117.5M
Gross Margin: $1.06B
Return on Equity: 1.95%
Return on Assets: 0.54%

The Carlyle Group Earnings Forecast

Key The Carlyle Group Financial Ratios

  • The Gross Profit Margin over the past 10 years for CG is 58.85%.
  • The Selling, General & Administrative Expenses for CG have been equal to 49.24% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 211.85% of Operating Income.
  • The Net Earning history of CG is -45.94% of Total Revenues.
  • Per Share Earnings over the last 15 years have been positive in 6 years.

The Carlyle Group Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Capital Markets
Sector: Financials
Current Symbol: CG
CUSIP: 14309L
Website: carlyle.com

Debt

Debt-to-Equity Ratio: 1.67
Current Ratio: 12.92
Quick Ratio: 12.92

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 11.85

CG Technical Analysis vs Fundamental Analysis

Buy
73
The Carlyle Group (CG) is a Buy

Is The Carlyle Group a Buy or a Sell?

  • The Carlyle Group stock is rated a Buy
    The current The Carlyle Group [CG] share price is $51.36. The Score for CG is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.